Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts

Annual Review of Pharmacology and Toxicology - Tập 43 Số 1 - Trang 149-173 - 2003
Xinxin Ding1, Laurence S. Kaminsky1
1Wadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York 12201

Tóm tắt

Cytochrome P450 (CYP) enzymes in extrahepatic tissues often play a dominant role in target tissue metabolic activation of xenobiotic compounds. They may also determine drug efficacy and influence the tissue burden of foreign chemicals or bioavailability of therapeutic agents. This review focuses on xenobiotic-metabolizing CYPs of the human respiratory and gastrointestinal tracts, including the lung, trachea, nasal respiratory and olfactory mucosa, esophagus, stomach, small intestine, and colon. Many CYPs are expressed in one or more of these organs, including CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2A13, CYP2B6, CYP2C8, CYP2C9, CYP2C18, CYP2C19, CYP2D6, CYP2E1, CYP2F1, CYP2J2, CYP2S1, CYP3A4, CYP3A5, and CYP4B1. Of particular interest are the preferential expression of certain CYPs in the respiratory tract and the regional differences in CYP expression profile in different parts of the gastrointestinal tract. Current research activities on the characterization of CYP expression, function, and regulation in these tissues, as well as future research needs, are discussed.

Từ khóa


Tài liệu tham khảo

10.1097/00008571-199602000-00002

10.3109/10408449109019571

10.1002/(SICI)1098-2280(1997)30:1<11::AID-EM3>3.0.CO;2-F

Plopper CG. 1993. Pulmonary bronchiolar epithelial cytotoxicity: microanatomical considerations. See Ref.14, pp. 1–24

10.3109/10408449509021612

10.1080/15287399409531825

10.3109/10408449709089898

Baron J, Voigt JM. 1993. Localization, distribution and induction of xenobiotic-metabolizing enzymes and aryl hydrocarbon hydroxylase activity within lung. See Ref.14, pp. 41–75

Devereux TR, Domin BA, Philpot RM. 1993. Xenobiotic metabolism by isolated pulmonary brochiolar and alveolar cells. See Ref.14, pp. 25–40

10.1177/000348949310200509

10.1146/annurev.pa.33.040193.002123

Ding X, Coon MJ. 1993. Extrahepatic microsomal forms: olfactory cytochrome P450. InCytochrome P450: Handbook of Experimental Pharmacology, ed. JB Schenkman, H Greim, pp. 351–61. New York: Springer-Verlag

10.1016/S0940-2993(99)80031-1

Gram TE, 1993, Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells.

10.1016/S0304-3835(01)00529-8

10.1165/ajrcmb.17.1.2783

Tang YM, 1999, Drug Metab. Dispos., 27, 274

Shimada T, 1996, Drug Metab. Dispos., 24, 515

10.1093/carcin/19.10.1867

Su T, 2000, Cancer Res., 60, 5074

10.1016/S0959-8049(98)00034-3

10.1006/bbrc.1997.7775

Zeldin DC, 1996, Mol. Pharmacol., 50, 1111

10.1006/bbrc.2001.4390

10.1021/bi00475a012

10.1165/ajrcmb.16.3.9070608

10.1021/bi00446a014

10.1097/00008571-199906000-00004

Su T, 1996, Drug Metab. Dispos., 24, 884

10.1016/S0006-2952(99)00015-5

10.1007/s004280050359

10.1006/taap.2000.8923

Ding X, Dahl AR. 2002. Olfactory mucosa: composition, enzymatic localization, and metabolism. InHandbook of Olfaction and Gustation, ed. RL Doty. New York: Marcel Dekker. 2nd ed.

10.1097/00008571-200111000-00007

10.1097/00008571-200011000-00001

Czerwinski M, 1991, Cancer Res., 51, 4636

Lanza DL, 1999, Drug Metab. Dispos., 27, 798

10.1021/tx00042a026

Thornton-Manning J, 1996, J. Pharmacol. Exp. Ther., 276, 21

10.1124/mol.61.2.255

Omiecinski CJ, 1990, Cancer Res., 50, 4315

10.1080/10408449891344173

10.1093/jnci/91.5.459

Spivack SD, 2001, Drug Metab. Dispos., 29, 916

10.1016/0006-2952(91)90474-J

Koehl W, 1996, Cancer Res., 56, 316

Ruangyuttikarn W, 1991, Drug Metab. Dispos., 19, 977

10.1006/taap.1997.8117

Dowsley TF, 1999, J. Pharmacol. Exp. Ther., 289, 641

Smith TJ, 1995, Cancer Res., 55, 5566

Schuller HM, 1987, IARC Sci. Publ., 84, 138

10.3109/01902149809087380

10.1002/mc.2940110203

10.1093/toxsci/51.2.195

10.1165/ajrcmb.14.6.8652187

Shields PG, 1993, Cancer Res., 53, 3486

10.1016/S0024-3205(99)00373-2

10.1006/bbrc.1999.1089

10.1124/jpet.302.2.416

10.1016/S0027-5107(01)00109-9

10.1006/bbrc.1999.1913

10.1042/bst0280042

10.1006/taap.1999.8756

10.1016/S0006-2952(98)00004-5

10.1093/jnci/82.16.1333

10.1016/S0304-3835(01)00809-6

10.1165/ajrcmb.22.3.3845

10.1159/000110309

Su T, 1998, Drug Metab. Dispos., 26, 822

10.1074/jbc.273.36.23454

10.1006/mcbr.2000.0187

10.1165/ajrcmb.21.2.3378

10.1124/dmd.30.5.548

10.1006/abbi.2001.2410

10.1016/S0016-5085(74)80135-6

10.1002/cpt1977222228

10.1289/ehp.793371

Rifkind AB, 1978, Cancer Res., 38, 1572

10.1172/JCI113156

10.1093/carcin/10.3.521

10.1111/j.1365-2125.1988.tb03331.x

de Waziers I, 1990, J. Pharmacol. Exp. Ther., 253, 387

10.1016/0006-2952(89)90194-9

10.1159/000138530

Laitnen M, Watkins JBIII . 1986. Mucosal biotransformations. See Ref.141, pp. 169–92

10.3109/10408449209089881

Smith PL. 1986. Gastrointestinal physiology. See Ref.141, pp. 1–28

Dressman JB, Yamada K. 1991. Animal models for oral drug absorption. InPharmaceutical Bioequivalence, ed. P Welling, FL Welling, pp. 235–66. New York: Dekker

10.1002/bdd.2510160502

10.1016/B978-0-12-592550-1.50016-7

10.1093/carcin/19.4.667

10.1006/cbir.1995.1007

Huang Q, 1992, Cancer Res., 52, 3547

10.1136/gut.36.2.259

10.1093/carcin/20.2.243

10.1093/carcin/17.7.1477

Tan W, 2000, Cancer Epi. Res. Prevent., 9, 551

10.1080/14766650252962658

10.1124/mol.51.6.931

10.1002/1097-0142(19940715)74:2<556::AID-CNCR2820740205>3.0.CO;2-J

Hirota T, Okada T, Itabashi M, Yoshida H, Matsujura H, et al. 1984. Significance of intestinal metaplasia as a precancerous condition of the stomach. InPrecursors of Gastric Cancer, ed. SC Ming, pp. 179–93. New York: Praeger

10.1111/j.1349-7006.1998.tb00492.x

Tatemichi M, 1999, Cancer Res., 59, 3893

10.1038/bjc.1998.173

10.1016/S0169-409X(97)00041-0

10.1021/js980082d

10.1016/S0169-409X(00)00126-5

10.1016/S0009-9236(96)90162-9

Zhang QY, 1999, Drug Metab. Dispos., 27, 804

10.1172/JCI119439

10.1016/S0027-5107(97)00038-9

Paine MF, 1999, Drug Metab. Dispos., 27, 360

Paine MF, 1997, J. Pharmacol. Exp. Ther., 283, 1552

Lown KS, 1994, Drug. Metab. Dispos., 22, 947

Obach RS, 2001, Drug Metab. Dispos., 29, 347

10.1146/annurev.pharmtox.39.1.1

10.1146/annurev.pharmtox.42.111901.111051

10.1006/bbrc.2000.4238

10.1016/0140-6736(91)90872-M

Miniscalco A, 1992, J. Pharmacol. Exp. Ther., 261, 1195

10.1111/j.1365-2125.1993.tb00396.x

10.1016/0024-3205(96)00417-1

10.2165/00003088-199733020-00003

10.2165/00002018-199818040-00002

10.1046/j.1365-2125.1998.t01-1-00687.x

10.1046/j.1365-2125.1999.00052.x

10.1007/s002280000229

Schmiedlin-Ren P, 1997, Drug Metab. Dispos., 25, 1228

Guo LQ, 2000, Drug Metab. Dispos., 28, 766

10.1006/bbrc.1995.1668

10.1016/0027-5107(93)90029-F

10.1016/S1382-6689(96)00075-0

Murray GI, 1997, Cancer Res., 57, 3026

10.1038/bjc.1993.286

Bonnesen C, 2001, Cancer Res., 61, 6120

Vasquez H, 2001, Int. J. Oncol., 18, 553

10.1124/mol.51.5.741

10.1080/10715760000301441

10.1093/oxfordjournals.alcalc.a008294

10.1016/S0006-2952(98)00208-1

Scheutz EG, 1996, Mol. Pharmacol., 49, 311

Thông tin
Thông tin xuất bản

Annual Review of Pharmacology and Toxicology

Tập 43 Số 1

149-173

Thông tin tác giả